CervoMed Inc.

NASDAQ: CRVO · Real-Time Price · USD
10.17
-0.02 (-0.20%)
At close: Aug 15, 2025, 3:59 PM
10.11
-0.59%
After-hours: Aug 15, 2025, 05:20 PM EDT

CervoMed Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.76M 1.92M 2.16M 1.94M 3.29M 2.35M 2.49M 1.53M n/a 1.41M n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 4.84M 7.09M 5.13M 8.04M 2.81M 2.85M 1.79M n/a 1.83M 380.69K 330.54K n/a 368.42K 26.11K 19.1K n/a n/a
Gross Profit
n/a -2.92M -4.92M -3.19M 3.29M -467K -365K -265K n/a -425K -381K -331K n/a n/a -26.11K -19.1K n/a n/a
Operating Income
-6.62M -5.3M -7.24M -5.4M -3M -2.6M -2.48M -2.67M -2.29M -4.27M -4.25M -2.92M -4.25M -4.55M -3.47M -4.05M -3.83M -4.68M
Interest Income
368.13K 408.99K 532.18K 646.17K 678.44K 80.63K 118.65K 47.67K 17.71K 35.4K 172.85K 21.52K 55.38K 27.81K n/a 50.71K 55.23K 40.42K
Pretax Income
-6.26M -4.89M -6.71M -4.75M -2.32M -2.51M -2.36M 2.15M -2.11M -4.09M -4.08M -2.8M -4.19M -4.53M -3.47M -12.64M -3.78M -4.64M
Net Income
-6.26M -4.89M -6.71M -4.75M -2.32M -2.51M -2.36M 2.15M -2.11M -4.09M -4.08M -883K -4.19M -4.53M -3.47M -12.2M -3.78M -4.64M
Selling & General & Admin
3.27M 2.38M 2.32M 2.21M 2.51M 2.13M 2.12M 2.41M 2.22M 1M 2.34M 2.13M 2.14M 2.13M 1.93M 1.93M 1.84M 1.74M
Research & Development
5.11M 4.84M 7.09M 5.13M 3.77M 2.81M 2.85M 1.79M 72.19K 1.31M 1.9M 798.25K 2.11M 2.43M 1.5M 2.11M 1.97M 2.92M
Other Expenses
n/a -4.84M -7.09M -5.13M 70.00 -2.81M -2.85M -1.79M n/a 856.58K n/a n/a n/a n/a 26.11K n/a 23.75K 24.45K
Operating Expenses
8.37M 2.38M 2.32M 2.21M 6.28M 2.13M 2.12M 2.41M 2.29M 4.27M 4.25M 2.92M 4.25M 4.55M 3.44M 4.04M 3.83M 4.68M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.79M 1.55M n/a n/a n/a n/a n/a n/a
Cost & Expenses
8.37M 7.22M 9.4M 7.34M 6.28M 4.94M 4.97M 4.2M 2.29M 4.27M 4.25M 2.92M 4.25M 4.55M 3.47M 4.05M 3.83M 4.68M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -904K n/a n/a -4 -444K n/a n/a
Shares Outstanding (Basic)
8.95M 8.7M 8.7M 8.7M 8.7M 6.17M 5.67M 3.31M 1.36M 1.36M 1.36M 1.36M 1.36M 1.36M 1.36M 1.36M 1.36M 1.1M
Shares Outstanding (Diluted)
8.95M 8.7M 8.7M 8.7M 8.7M 6.17M 5.67M 3.77M 1.36M 1.36M 1.36M 1.36M 1.36M 1.36M 1.36M 1.36M 1.36M 1.1M
EPS (Basic)
-0.7 -0.56 -0.77 -0.55 -0.27 -0.41 -0.42 0.65 -1.55 -3.01 -3 -1.7 -3.08 -3.33 -2.56 -8.98 -2.78 -4.21
EPS (Diluted)
-0.7 -0.56 -0.77 -0.55 -0.27 -0.41 -0.42 -0.7 -1.55 -3.01 -3 -1.7 -3.08 -3.33 -2.56 -8.98 -2.78 -4.21
EBITDA
-6.62M -5.3M -7.24M -5.4M -3M -2.6M -2.36M -2.67M -1.23M -1.43M -4.08M -904K -4.25M -4.53M -3.44M -4.04M -3.81M -4.66M
EBIT
-6.26M -5.3M -7.24M -5.4M -3M -2.6M -2.36M -2.67M -2.11M -4.09M -4.25M -2.8M -4.25M -4.55M -3.47M -4.05M -3.83M -4.68M
Depreciation & Amortization
n/a 4.00 n/a n/a n/a n/a n/a 2.67M 1.23M 1.43M 938.82K 904.05K n/a 882.5K 26.11K 19.1K 23.75K 24.45K